Cargando…

Gelsolin Promotes Cancer Progression by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma and Correlates with a Poor Prognosis

Gelsolin (GSN), a cytoskeletal protein, is frequently overexpressed in different cancers and promotes cell motility. The biological function of GSN in hepatocellular carcinoma (HCC) and its mechanism remain unclear. The expression of GSN was assessed in a cohort of 188 HCC patients. The effects of G...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yixi, Luo, Xiaojing, Lin, Jianwei, Fu, Shunjun, Feng, Pei, Su, Hongjun, He, Xiangjun, Liang, Xue, Liu, Kunpeng, Deng, Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199561/ https://www.ncbi.nlm.nih.gov/pubmed/32377190 http://dx.doi.org/10.1155/2020/1980368

Ejemplares similares

Involvement of gelsolin in TGF-beta 1 induced epithelial to mesenchymal transition in breast cancer cells
por: Chen, Zhi-Yuan, et al.
Publicado: (2015)

Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial–mesenchymal transition
por: He, Lu, et al.
Publicado: (2014)

GIT1 overexpression promotes epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma
por: Wang, Guifu, et al.
Publicado: (2020)

Overexpression of long non-coding RNA CRNDE facilitates epithelial-mesenchymal transition and correlates with poor prognosis in intrahepatic cholangiocarcinoma
por: Xia, Xiu-Liang, et al.
Publicado: (2018)

Actin‐like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial‐mesenchymal transition
por: Xiao, Shuai, et al.
Publicado: (2016)

RETRACTED ARTICLE: Sorcin Predicts Poor Prognosis and Promotes Metastasis by Facilitating Epithelial-mesenchymal Transition in Hepatocellular Carcinoma
por: Lei, Xiong, et al.
Publicado: (2017)

PDE4a predicts poor prognosis and promotes metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma
por: Peng, Yanghong, et al.
Publicado: (2018)

Retraction Note: Sorcin Predicts Poor Prognosis and Promotes Metastasis by Facilitating Epithelial-mesenchymal Transition in Hepatocellular Carcinoma
por: Lei, Xiong, et al.
Publicado: (2018)

Cullin 4A is associated with epithelial to mesenchymal transition and poor prognosis in perihilar cholangiocarcinoma
por: Zhang, Tong-Jun, et al.
Publicado: (2017)

Plasma gelsolin promotes re-epithelialization
por: Wittmann, J., et al.
Publicado: (2018)

TRPV4 Overexpression Promotes Metastasis Through Epithelial–Mesenchymal Transition in Gastric Cancer and Correlates with Poor Prognosis
por: Wang, Huafeng, et al.
Publicado: (2020)

Plastin3 is associated with epithelial-mesenchymal transition and poor prognosis in gastric cancer
por: Kurashige, Junji, et al.
Publicado: (2019)

TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection
por: Wang, Cheng-Hao, et al.
Publicado: (2015)

HMGA2 is associated with epithelial–mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinoma
por: Xia, You-You, et al.
Publicado: (2015)

CD146 Expression Correlates with Epithelial-Mesenchymal Transition Markers and a Poor Prognosis in Gastric Cancer
por: Liu, Wen-Fang, et al.
Publicado: (2012)

Pentraxin 3 overexpression accelerated tumor metastasis and indicated poor prognosis in hepatocellular carcinoma via driving epithelial-mesenchymal transition
por: Song, Tao, et al.
Publicado: (2018)

Rac1 overexpression is correlated with epithelial mesenchymal transition and predicts poor prognosis in non-small cell lung cancer
por: Zhou, Yujuan, et al.
Publicado: (2016)

MST4 Predicts Poor Prognosis And Promotes Metastasis By Facilitating Epithelial–Mesenchymal Transition In Gastric Cancer
por: Li, Taiyuan, et al.
Publicado: (2019)

A Novel Epithelial-Mesenchymal Transition Gene Signature Correlated With Prognosis, and Immune Infiltration in Hepatocellular Carcinoma
por: Kong, Weihao, et al.
Publicado: (2022)

BTBD7 Downregulates E-Cadherin and Promotes Epithelial-Mesenchymal Transition in Lung Cancer
por: Shu, Jie, et al.
Publicado: (2019)

Overexpression of SPARC correlates with poor prognosis in patients with cervical carcinoma and regulates cancer cell epithelial-mesenchymal transition
por: SHI, DEHUAN, et al.
Publicado: (2016)

DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma
por: Chen, Jin, et al.
Publicado: (2019)

Podocalyxin‐like protein, linked to poor prognosis of pancreatic cancers, promotes cell invasion by binding to gelsolin
por: Taniuchi, Keisuke, et al.
Publicado: (2016)

HOXC6 predicts invasion and poor survival in hepatocellular carcinoma by driving epithelial-mesenchymal transition
por: Li, Pin-Dong, et al.
Publicado: (2018)

CYB5R1 links epithelial-mesenchymal transition and poor prognosis in colorectal cancer
por: Woischke, Christine, et al.
Publicado: (2016)

RASSF6 downregulation promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal cancer
por: Zhou, Rui, et al.
Publicado: (2017)

MACC1 Is Associated With Epithelial–Mesenchymal Transition and Can Predict Poor Prognosis in Nasopharyngeal Carcinoma
por: Cheng, Hao, et al.
Publicado: (2021)

Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma
por: Sun, Liang, et al.
Publicado: (2018)

HspB5 correlates with poor prognosis in colorectal cancer and prompts epithelial-mesenchymal transition through ERK signaling
por: Li, Qinghua, et al.
Publicado: (2017)

Physical Interaction between HPV16E7 and the Actin-Binding Protein Gelsolin Regulates Epithelial-Mesenchymal Transition via HIPPO-YAP Axis
por: Matarrese, Paola, et al.
Publicado: (2021)

An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients
por: Zhu, Gongmin, et al.
Publicado: (2021)

A novel epithelial–mesenchymal transition gene signature for the immune status and prognosis of hepatocellular carcinoma
por: Shi, Yanlong, et al.
Publicado: (2022)

Collagen XVII/laminin-5 activates epithelial-to-mesenchymal transition and is associated with poor prognosis in lung cancer
por: Liu, Chen-Chi, et al.
Publicado: (2016)

High Expression of Peroxiredoxin 1 Is Associated with Epithelial-Mesenchymal Transition Marker and Poor Prognosis in Gastric Cancer
por: Yu, Wei, et al.
Publicado: (2018)

High PKD2 predicts poor prognosis in lung adenocarcinoma via promoting Epithelial–mesenchymal Transition
por: Pang, Zhaofei, et al.
Publicado: (2019)

RUFY3 Predicts Poor Prognosis and Promotes Metastasis through Epithelial-mesenchymal Transition in Lung Adenocarcinoma
por: Men, Wanfu, et al.
Publicado: (2019)

Decreased chromobox homologue 7 expression is associated with epithelial–mesenchymal transition and poor prognosis in cervical cancer
por: Tian, Ping, et al.
Publicado: (2021)

ARNTL2 is an indicator of poor prognosis, promotes epithelial-to-mesenchymal transition and inhibits ferroptosis in lung adenocarcinoma
por: Zhang, Huan, et al.
Publicado: (2022)

Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma
por: Zhu, Zebin, et al.
Publicado: (2018)

Sorafenib inhibits macrophage-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
por: Deng, Yan-Ru, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pfe28jbbp4qso52bm95k4p30j3